Pyrrolobenzodiazepine antibody conjugates
Abstract:
The present disclosure relates generally to antibody-drug conjugates comprising pyrrolo[2, 1-c][1, 4]benzodiazepine (PBD) drug moieties. The present disclosure also relates to methods of using these conjugates, e.g., as therapeutics and/or diagnostics.
Public/Granted literature
Information query
Patent Agency Ranking
0/0